Which children should receive growth hormone treatment. Cost-benefit analysis is the key.
Kelnar
C J
CJ
Department of Child Life and Health, University of Edinburgh, Scotland, UK. chriskelnar@hotmail.com
D002648:Child; D003362:Cost-Benefit Analysis; D004992:Ethics, Medical; D005260:Female; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018579:Patient Selection; D016896:Treatment Outcome
D019382:Human Growth Hormone